MBS Review Taskforce Report on Urology

This ensures that GPS will be informed early after diagnosis of prostate cancer, and will be in a better position to support the patient after diagnosis. The Committee recommends that the schedule fee for this item should be set at a level 20% lower than the existing schedule fee for item 37219 to ensure overall cost neutrality (given the ... ................
................